The GLP-1 response from dietary EVOO, while statistically significant, is part of the normal postprandial hormonal cascade -- a nudge, not a pharmacological override
For patients who match the Amazon profile - insured, located in a One Medical market, comfortable with a more involved clinical onboarding process, and interested in having GLP-1 treatment managed as part of an integrated primary care relationship - Amazon One Medical is a genuinely excellent choice
Mechanisms underlying cardiovascular effects of incretin therapy In addition to glycemic effects, GLP-1RAs also favorably modulate multiple cardiovascular risk factors via acting on a variety of organ systems
Electrolyte supplements do not interfere with how GLP-1 medications work
We frequently see patients who struggle with weight gain despite consistent effort due to hormonal imbalances, metabolic dysfunction, or genetic predispositions, where a standard diet alone is not enough